TipRanks
West Pharmaceutical Services, Inc. (MX:WST)
:WST
Mexico Market
WST
West Pharmaceutical Services
RESEARCH TOOLSreports

West Pharmaceutical Services (WST) Ratios

1 Followers

West Pharmaceutical Services Ratios

MX:WST's free cash flow for Q3 2026 was $0.40. For the 2026 fiscal year, MX:WST's free cash flow was decreased by $ and operating cash flow was $0.31. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 2.82 3.02 2.79 2.88 3.70
Quick Ratio
 2.10 2.34 2.11 2.24 2.90
Cash Ratio
 0.72 1.21 0.88 1.27 1.72
Solvency Ratio
 0.75 0.61 0.67 0.77 0.76
Operating Cash Flow Ratio
 1.02 1.15 1.19 1.16 1.39
Short-Term Operating Cash Flow Coverage
 0.00 33.25 34.76 5.79 329.09
Net Current Asset Value
$ 724.00M$ 884.20M$ 577.00M$ 987.90M$ 987.60M
Leverage Ratios
Debt-to-Assets Ratio
 0.08 0.10 0.08 0.08 0.09
Debt-to-Equity Ratio
 0.10 0.13 0.11 0.11 0.12
Debt-to-Capital Ratio
 0.09 0.12 0.10 0.10 0.11
Long-Term Debt-to-Capital Ratio
 0.06 0.09 0.07 0.02 0.07
Financial Leverage Ratio
 1.37 1.34 1.36 1.33 1.35
Debt Service Coverage Ratio
 0.00 27.85 29.32 5.05 70.76
Interest Coverage Ratio
 0.00 1.03K 205.03 80.78 100.46
Debt to Market Cap
 <0.01 0.02 <0.01 <0.01 0.01
Interest Debt Per Share
 4.33 5.77 4.22 4.28 4.38
Net Debt to EBITDA
 -0.16 -0.49 -0.24 -0.65 -0.71
Profitability Margins
Gross Profit Margin
37.59%35.89%34.65%38.38%39.47%
EBIT Margin
23.06%19.49%20.34%23.95%23.83%
EBITDA Margin
28.47%25.07%25.71%28.60%28.01%
Operating Profit Margin
22.97%20.09%20.56%24.09%26.46%
Pretax Profit Margin
23.36%20.02%20.75%24.25%24.28%
Net Profit Margin
18.81%16.06%17.03%20.11%20.30%
Continuous Operations Profit Margin
18.40%16.06%17.03%20.11%20.30%
Net Income Per EBT
80.54%80.24%82.09%82.91%83.63%
EBT Per EBIT
101.68%99.66%100.94%100.68%91.76%
Return on Assets (ROA)
15.73%11.56%13.52%15.50%16.20%
Return on Equity (ROE)
21.08%15.54%18.37%20.60%21.82%
Return on Capital Employed (ROCE)
22.84%17.08%19.22%22.51%24.65%
Return on Invested Capital (ROIC)
17.89%13.62%15.69%17.81%20.49%
Return on Tangible Assets
16.19%11.89%13.97%16.01%16.78%
Earnings Yield
2.20%2.48%2.06%2.27%3.35%
Efficiency Ratios
Receivables Turnover
 4.54 5.35 5.24 5.76 5.69
Payables Turnover
 8.50 7.77 7.90 7.50 8.11
Inventory Turnover
 4.56 4.44 5.01 4.18 4.21
Fixed Asset Turnover
 1.92 1.67 1.72 1.95 2.29
Asset Turnover
 0.84 0.72 0.79 0.77 0.80
Working Capital Turnover Ratio
 2.90 2.66 2.57 2.21 2.26
Cash Conversion Cycle
 117.47 103.44 96.30 101.93 105.85
Days of Sales Outstanding
 80.40 68.21 69.71 63.33 64.18
Days of Inventory Outstanding
 80.01 82.23 72.79 87.26 86.68
Days of Payables Outstanding
 42.94 47.00 46.20 48.66 45.01
Operating Cycle
 160.41 150.44 142.50 150.58 150.87
Cash Flow Ratios
Operating Cash Flow Per Share
 9.30 10.44 8.95 10.45 9.73
Free Cash Flow Per Share
 6.44 6.49 3.79 5.58 5.91
CapEx Per Share
 2.86 3.95 5.16 4.87 3.83
Free Cash Flow to Operating Cash Flow
 0.69 0.62 0.42 0.53 0.61
Dividend Paid and CapEx Coverage Ratio
 2.48 2.17 1.50 1.85 2.14
Capital Expenditure Coverage Ratio
 3.25 2.64 1.73 2.15 2.54
Operating Cash Flow Coverage Ratio
 2.15 1.81 2.14 2.51 2.28
Operating Cash Flow to Sales Ratio
 0.19 0.25 0.23 0.26 0.25
Free Cash Flow Yield
1.56%2.36%1.16%1.58%2.51%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 46.00 40.28 48.53 44.09 29.89
Price-to-Sales (P/S) Ratio
 8.55 6.47 8.27 8.87 6.07
Price-to-Book (P/B) Ratio
 9.79 6.26 8.91 9.08 6.52
Price-to-Free Cash Flow (P/FCF) Ratio
 64.05 42.42 86.51 63.12 39.85
Price-to-Operating Cash Flow Ratio
 44.38 26.35 36.60 33.69 24.19
Price-to-Earnings Growth (PEG) Ratio
 1.43 33.99 -3.13 31.58 -2.61
Enterprise Value Multiple
 29.87 25.33 31.91 30.35 20.95
Enterprise Value
 28.88B 19.52B 23.73B 25.62B 16.93B
EV to EBITDA
 29.87 25.33 31.91 30.35 20.95
EV to Sales
 8.50 6.35 8.20 8.68 5.87
EV to Free Cash Flow
 63.70 41.63 85.86 61.80 38.54
EV to Operating Cash Flow
 44.12 25.86 36.32 32.99 23.39
Tangible Book Value Per Share
 40.53 42.30 35.14 37.11 34.40
Shareholders’ Equity Per Share
 42.16 43.93 36.74 38.78 36.09
Tax and Other Ratios
Effective Tax Rate
 0.21 0.20 0.18 0.17 0.16
Revenue Per Share
 48.25 42.51 39.63 39.72 38.78
Net Income Per Share
 9.08 6.83 6.75 7.99 7.88
Tax Burden
 0.81 0.80 0.82 0.83 0.84
Interest Burden
 1.01 1.03 1.02 1.01 1.02
Research & Development to Revenue
 0.02 0.02 0.02 0.02 0.02
SG&A to Revenue
 0.13 0.13 0.12 0.00 0.00
Stock-Based Compensation to Revenue
 <0.01 <0.01 <0.01 <0.01 <0.01
Income Quality
 1.02 1.53 1.33 1.31 1.24
Currency in USD